These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1752645)

  • 1. Autologous bone marrow transplantation.
    Kochupillai V; Kumar L; Anandhi R
    Indian J Pathol Microbiol; 1991 Apr; 34(2):152-9. PubMed ID: 1752645
    [No Abstract]   [Full Text] [Related]  

  • 2. The rationale of autologous bone marrow transplantation.
    Mandelli F; Meloni G
    Bone Marrow Transplant; 1991; 7 Suppl 2():66-7. PubMed ID: 1878725
    [No Abstract]   [Full Text] [Related]  

  • 3. Allogeneic bone marrow transplantation in haematological malignancies. Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT).
    Gahrton G; Gratwohl A; Ernst P; Hermans J; Lyklema A; Zwaan FE
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():4-6. PubMed ID: 2627623
    [No Abstract]   [Full Text] [Related]  

  • 4. The combined use of elutriation and CD8/magnetic bead separation to engineer the bone marrow allograft.
    Noga SJ; Davis JM; Vogelsang GB; Donnenberg AD; Thoburn C; Schepers K; Sproul J
    Prog Clin Biol Res; 1992; 377():411-8. PubMed ID: 1438439
    [No Abstract]   [Full Text] [Related]  

  • 5. Autologous bone marrow and peripheral blood stem cell transplantation in haematological malignancies: current status.
    Marcoullis G; Mehta J; Treleaven J
    Med Oncol; 1995 Dec; 12(4):209-18. PubMed ID: 8832524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autologous bone marrow transplantation in malignant hematologic diseases].
    Johnsen HE; Birgens H; Hansen NE
    Ugeskr Laeger; 1991 Jun; 153(25):1790-3. PubMed ID: 1853458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow transplantation activity in Europe 1992: report from the European Group for Bone Marrow Transplantation (EBMT).
    Gratwohl A; Hermans J
    Bone Marrow Transplant; 1994 Jan; 13(1):5-10. PubMed ID: 8019452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications of autologous bone marrow transplantation].
    Conde E; Iriondo A
    Med Clin (Barc); 1989 Feb; 92(5):171-3. PubMed ID: 2657256
    [No Abstract]   [Full Text] [Related]  

  • 9. Autologous blood stem cell transplantation in hematologic malignancies.
    Majolino I; Scimé R; Indovina A
    Haematologica; 1990; 75(6):555-66. PubMed ID: 1983000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Difference in costs of autologous transplantation of peripheral and bone marrow hematopoietic stem cells. A retrospective analysis over 1 year of transplantation in lymphoma, Hodgkin's disease and myeloma in a Center].
    Rio B; Marjanovic Z; Belhocine R; Vekhoff A; Andrieu V; Klaren J; Boccaccio C; Delmer A; Ajchenbaum-Cymbalista F; Hunault M; Bazarbachi A; Lévy V; Andreu G; Zittoun R
    Ann Med Interne (Paris); 1996; 147(5):313-9. PubMed ID: 9033732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
    Baron F; Gothot A; Salmon JP; Hermanne JP; Pierard GE; Fillet G; Beguin Y
    Br J Haematol; 2000 Dec; 111(3):745-53. PubMed ID: 11122133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro manipulation of bone marrow cells for bone marrow transplantation].
    Morishima Y
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3034-43. PubMed ID: 3056275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation of peripheral lymphocytes to interleukin-2 and interleukin-4 after marrow transplantation.
    Klingemann HG; Kohn FR; Phillips GL
    Eur Cytokine Netw; 1991; 2(2):131-6. PubMed ID: 1813016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autologous bone marrow transplantation in malignant hematogenous tumor of adults--the current status and problems in Japan].
    Harada M; Asano S
    Rinsho Ketsueki; 1992 Jul; 33(7):934-9. PubMed ID: 1507415
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow transplantation for the treatment of refractory malignancies.
    Decter JA; Bekele W; Ahmed T
    N J Med; 1993 Apr; 90(4):307-9. PubMed ID: 8506093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of GM-CSF in bone marrow transplantation.
    Vose JM; Armitage JO
    Behring Inst Mitt; 1991 Dec; (90):39-43. PubMed ID: 1801689
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies.
    Catani L; Gugliotta L; Mattioli Belmonte M; Vianelli N; Gherlinzoni F; Miggiano MC; Belardinelli AR; Rosti G; Calori E; Bandini G
    Bone Marrow Transplant; 1993 Sep; 12(3):253-9. PubMed ID: 8241985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of recombinant IL-2 (RU49637) after autologous bone marrow transplantation (BMT) in patients with hematological neoplasias: a phase 1 study.
    Blaise D; Stoppa AM; Olive D; Brandely M; Tiberghien P; Attal M; Attal J; Reiffers J; Demeocq F; Pico JL
    Bone Marrow Transplant; 1991; 7 Suppl 2():146. PubMed ID: 1878687
    [No Abstract]   [Full Text] [Related]  

  • 19. [Allogenic transplantation of bone marrow in hematologic diseases. Preparation and completion of transplantation at the Hematology Clinic in Novi Sad].
    Pejin D; Popović S; Dokić M; Felle D; Stefanović N
    Acta Chir Iugosl; 1990; 37 Suppl 1():11-5. PubMed ID: 2109441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognosis of hematological patients with relapse following high-dose chemotherapy and autologous stem cell transplantation].
    Baggers J; Johnsen HE
    Ugeskr Laeger; 1998 Sep; 160(38):5505-8. PubMed ID: 9763925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.